Literature DB >> 7592629

Adenovirus-mediated overexpression of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in gluconeogenic rat hepatoma cells. Paradoxical effect on Fru-2,6-P2 levels.

D Argaud1, A J Lange, T C Becker, D A Okar, M R el-Maghrabi, C B Newgard, S J Pilkis.   

Abstract

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase has been postulated to be a metabolic signaling enzyme, which acts as a switch between glycolysis and gluconeogenesis in mammalian liver by regulating the level of fructose 2,6-bisphosphate. The effect of overexpressing the bifunctional enzyme was studied in FAO cells transduced with recombinant adenoviral constructs of either the wild-type enzyme or a double mutant that has no bisphosphatase activity or protein kinase phosphorylation site. With both constructs, the mRNA and protein were overexpressed by 150- and 40-fold, respectively. Addition of cAMP to cells overexpressing the wild-type enzyme increased the S0.5 for fructose 6-phosphate of the kinase by 1.5-fold but had no effect on the overexpressed double mutant. When the wild-type enzyme was overexpressed, there was a decrease in fructose 2,6-bisphosphate levels, even though 6-phosphofructo-2-kinase maximal activity increased more than 22-fold and was in excess of fructose-2,6-bisphosphatase maximal activity. The kinase:bisphosphatase maximal activity ratio was decreased, indicating that the overexpressed enzyme was phosphorylated by cAMP-dependent protein kinase. Overexpression of the double mutant resulted in a 28-fold increase in kinase maximal activity and a 3-4-fold increase in fructose 2,6-bisphosphate levels. Overexpression of this form inhibited the rate of glucose production from dihydroxyacetone by 90% and stimulated the rate of lactate plus pyruvate production by 200%. In contrast, overexpression of the wild-type enzyme enhanced glucose production and inhibited lactate plus pyruvate production. These results provide direct support for fructose 2,6-bisphosphate as a regulator of gluconeogenic/glycolytic pathway flux and suggest that regulation of bifunctional enzyme activities by covalent modification is more important than the amount of the protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592629     DOI: 10.1074/jbc.270.41.24229

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells.

Authors:  Joshua K Salabei; Pawel K Lorkiewicz; Parul Mehra; Andrew A Gibb; Petra Haberzettl; Kyung U Hong; Xiaoli Wei; Xiang Zhang; Qianhong Li; Marcin Wysoczynski; Roberto Bolli; Aruni Bhatnagar; Bradford G Hill
Journal:  J Biol Chem       Date:  2016-05-05       Impact factor: 5.157

2.  Overexpression of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase in mouse liver lowers blood glucose by suppressing hepatic glucose production.

Authors:  C Wu; D A Okar; C B Newgard; A J Lange
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Xylitol prevents NEFA-induced insulin resistance in rats.

Authors:  P Kishore; S Kehlenbrink; M Hu; K Zhang; R Gutierrez-Juarez; S Koppaka; M R El-Maghrabi; M Hawkins
Journal:  Diabetologia       Date:  2012-03-30       Impact factor: 10.122

4.  A role for inducible 6-phosphofructo-2-kinase in the control of neuronal glycolysis.

Authors:  Honggui Li; Xin Guo; Hang Xu; Shih-Lung Woo; Vera Halim; Caurnel Morgan; Chaodong Wu
Journal:  J Nutr Biochem       Date:  2012-12-14       Impact factor: 6.048

5.  Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases.

Authors:  Abdullah Yalcin; Brian F Clem; Alan Simmons; Andrew Lane; Kristin Nelson; Amy L Clem; Erin Brock; Deanna Siow; Binks Wattenberg; Sucheta Telang; Jason Chesney
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.